News

Sky Medical Technology Expands Reach with New Partnership

Sky Medical Technology Expands Reach with New Partnership

Sky Medical Technology Partners with SMS Medical

Sky Medical Technology, a leading manufacturer in medical devices, has entered into a strategic distribution agreement with SMS Medical. This partnership aims to provide enhanced recovery solutions after orthopedic surgeries by offering the geko device. The geko device is designed specifically to eliminate edema and prevent deep vein thrombosis (DVT), which can pose serious risks to patients after surgery.

Addressing Challenges in Post-Surgery Recovery

After orthopedic surgery, many patients can experience swelling, or edema, which significantly hampers recovery and can lead to complications such as surgical site infections. The geko device has been clinically validated as a unique muscle pump activator, effectively reducing lower limb edema through its innovative design. This activation promotes blood circulation, which is crucial for patients during their recovery phase.

Benefits of the geko Device

The geko device is not only focused on reducing swelling but also plays a pivotal role in the prevention of DVT, especially for patients who are immobile or suffer from other medical conditions. By enhancing venous blood flow, the geko device helps mitigate the risks associated with DVT, making recovery safer for patients.

Significance of the Agreement

The collaboration between Sky Medical Technology and SMS Medical signifies a major step in making advanced medical solutions more accessible. SMS Medical, recognized for its leadership in orthopedic device solutions, will help distribute the geko device across the Southeast United States, promoting faster recovery times for postoperative patients.

The Importance of Enhanced Recovery After Surgery (ERAS)

This partnership also aligns with the broader Enhanced Recovery After Surgery (ERAS) framework. ERAS is designed to streamline the recovery process through various interventions, leading to quicker patient recovery times and better overall outcomes. By incorporating the geko device into these protocols, SMS Medical can enhance their offerings and help surgeons and patients maximize their postoperative recovery.

Looking Ahead

As both companies work together, the focus will remain on delivering high-quality recovery solutions that place patient safety and comfort first. The geko device has shown promising results, and with the backing of SMS Medical's extensive network, its availability will be greatly enhanced. This collaboration is expected to lead to more research and development in the field, aiming for innovations that further improve patient care following orthopedic procedures.

Future Innovations in Orthopedic Care

Sky Medical Technology is committed to its mission of revolutionizing orthopedic recovery, not only through the geko device but also by exploring other potential innovations. The company aims to continually improve its offerings based on the latest clinical insights and patient feedback, leading to enhanced recovery processes in the future.

Frequently Asked Questions

What is the geko device?

The geko device is a wearable muscle pump activator designed to reduce lower limb edema and prevent deep vein thrombosis in patients after orthopedic surgery.

How does the geko device work?

The geko device activates the muscles in the lower leg to improve circulation, which helps reduce swelling and prevents blood clots.

Why is the partnership with SMS Medical significant?

This partnership allows Sky Medical Technology to expand the availability of the geko device in the Southeast United States, improving patient recovery outcomes.

What does ERAS stand for?

ERAS stands for Enhanced Recovery After Surgery, a protocol aimed at improving recovery times and outcomes for surgical patients.

How can patients access the geko device?

Patients can access the geko device through their healthcare providers, especially in facilities equipped with SMS Medical's offerings following orthopedic procedures.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sequel Advisors Rebrand: Founder-Centric M&A Focus

Updated Category News Views 2

What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...

Continue Reading
Wrensilva Unveils Studio Console in White Oak

Updated Category News Views 2

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Continue Reading
Stravito's MCP Server Revolutionizes AI in Business

Updated Category News Views 2

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

Continue Reading
Synopsys-TSMC Collaboration Drives AI System Evolution

Updated Category News Views 4

Synopsys and TSMC: The New Power Couple in AI Ah, the world of semiconductors—where the chips are small but the stakes are colossal. Once again, Synopsys and TSMC have thrown their hats into the ring, diving headfirst into yet another ambitious collaboration. Their latest mission? To fast-track the evolution of AI systems through a suite of innovations strapped to...

Continue Reading
Decision Logic Innovates with Vitals & ShiftFlow Tools

Updated Category News Views 4

Restaurant Battlefields: The Need for Real-Time Response Running a restaurant is no walk in the park. One slip, and you're dealing with spoiled soup or crabby customers. Decision Logic reckons they've cracked the code to smoother operations with their new tools, Vitals and ShiftFlow. At heart, these products do one thing: put critical data into the hands of managers while...

Continue Reading
Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 2

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
Amy Wilson Joins ITSA Board: A New Era for UBI?

Updated Category News Views 5

An Unexpected Turn in the UBI Movement In a world where tech and economic security must dance together, minding the steps is crucial. And this time, Amy Wilson's got her dancing shoes on. On September 24, 2026, the Income To Support All (ITSA) Foundation made some waves by adding Wilson to its board of directors, a move showing they're more serious than ever about...

Continue Reading
PostalAnnex Lands at Stanford with New Service Hub

Updated Category News Views 2

PostalAnnex Makes a Strategic Stanford Move It's not every day you see a company nestling into a place like Stanford University. Annex Brands has just opened its latest PostalAnnex location, a stone’s throw from the academic hustle and bustle of the Stanford campus. The geeky vibe of students and professors rushing with deadlines matches well with the efficient service...

Continue Reading
FSC Revives Frank Lloyd Wright's Planetarium Magic

Updated Category News Views 5

The cosmos are back on the show menu at Florida Southern College, folks. Let's dig into what that means for history buffs and star gazers alike. We're talking about the big reopening of the college's Frank Lloyd Wright designed Planetarium—a space that's been gathering dust for far too long. Dive in with me to see why this is more than just a coat of paint on an old...

Continue Reading
Newmark's $482.5M Loan Fuels Steamboat Resort Expansion

Updated Category News Views 4

Newmark Banks on Steamboat's Future Diving headfirst into the deep end, Newmark (NASDAQ: NMRK) just roped in a colossal $482.5 million loan for a new gem in Steamboat Springs, Colorado. Inking a deal of this magnitude ain't your everyday rinse-and-repeat; it's a bold move that speaks volumes about where the big shots think value's heading. The Financial Fuel: GoldenTree...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Developments Regarding Reconnaissance Energy Securities Case

Updated Category News Views 45

Overview of the Reconnaissance Energy Africa Ltd. Case Recent developments reveal that anyone who bought common stock of Reconnaissance Energy Africa Ltd. or its predecessor, Lund Enterprises Corp., on the U.S. OTC market is now being informed about a certified class action lawsuit. This notice is particularly relevant to those who purchased shares under the ticker...

Continue Reading
Red Violet to Share Exciting Q3 Financial Insights Soon

Updated Category News Views 122

Anticipating Q3 Financial Results from Red Violet Red Violet, Inc. (NASDAQ: RDVT), known for its innovative analytics and information solutions, is set to announce its financial results for the third quarter. This significant milestone will occur after the U.S. financial markets close on a day that promises to offer transparency into the company's recent performance....

Continue Reading
Global Atomic Corporation Secures C$35 Million Offering Increase

Updated Category News Views 125

Global Atomic Corporation's Public Offering Upsized to C$35 Million In a significant move, Global Atomic Corporation is thrilled to announce the upsizing of its public offering to gross proceeds of C$35 million. This decision was spurred by high investor demand, reflecting the growing interest in the company's future prospects. Details of the Offering The previously...

Continue Reading
Aircraft Delivery Delays: Insights from SMBC Aviation's CEO

Updated Category News Views 206

Challenges Facing Aircraft Deliveries The aviation industry is currently grappling with significant delays in aircraft deliveries, as highlighted by Peter Barrett, the CEO of SMBC Aviation Capital. Speaking at a conference, he noted that almost every new aircraft from major manufacturers like Boeing and Airbus is affected. Understanding the Cause of Delays These delivery...

Continue Reading
Alzamend Neuro Preps for Upcoming PTSD Drug Study in 2025

Updated Category News Views 177

Alzamend Neuro's New Study for PTSD Treatment Alzamend Neuro, Inc. has exciting plans on the horizon as it prepares to launch a Phase 2 clinical study of its lead drug, AL001, aimed at helping patients battling post-traumatic stress disorder (PTSD). This study is set to begin in the fourth quarter of 2025, aiming to explore innovative solutions for those affected by this...

Continue Reading